First Time Loading...

Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 20.08 USD 3.61% Market Closed
Updated: May 4, 2024

Kiniksa Pharmaceuticals Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Revenue Peer Comparison

Comparables:

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Revenue
$301.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Kiniksa Pharmaceuticals Ltd
Revenue Breakdown

Breakdown by Geography
Kiniksa Pharmaceuticals Ltd

Not Available

Breakdown by Segments
Kiniksa Pharmaceuticals Ltd

Total Revenue: 270.3m USD
100%
Product: 233.2m USD
86.3%
Collaboration: 37.1m USD
13.7%

See Also

What is Kiniksa Pharmaceuticals Ltd's Revenue?
Revenue
301.8m USD

Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Revenue amounts to 301.8m USD.

What is Kiniksa Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 1Y
28%

Over the last year, the Revenue growth was 28%.